15 research outputs found
Significant Reduction of Antibiotic Use in the Community after a Nationwide Campaign in France, 2002â2007
Didier Guillemot and colleagues describe the evaluation of a nationwide programme in France aimed at decreasing unnecessary outpatient prescriptions for antibiotics. The campaign was successful, particularly in reducing prescriptions for children
WSES guidelines for management of Clostridium difficile infection in surgical patients
In the last two decades there have been dramatic changes in the epidemiology of Clostridium difficile infection (CDI), with increases in incidence and severity of disease in many countries worldwide. The incidence of CDI has also increased in surgical patients. Optimization of management of C difficile, has therefore become increasingly urgent. An international multidisciplinary panel of experts prepared evidenced-based World Society of Emergency Surgery (WSES) guidelines for management of CDI in surgical patients.Peer reviewe
Efeitos da pressĂŁo positiva contĂnua em vias aĂ©reas sobre os sintomas nasofarĂngeos em pacientes com a sĂndrome da apnĂ©ia obstrutiva do sono Effects of continuos positive airway pressure on nasal and pharyngeal symptoms in patients with obstructive sleep apnea
INTRODUĂĂO: Sintomas nasofarĂngeos sĂŁo comuns em pacientes com a sĂndrome da apnĂ©ia obstrutiva do sono (SAOS) em tratamento com pressĂŁo positiva contĂnua em vias aĂ©reas (CPAP). No entanto, sintomas nasofarĂngeos sĂŁo tambĂ©m comuns em pacientes com SAOS antes do inĂcio do tratamento. OBJETIVO: Determinar o impacto do tratamento com CPAP nasal sobre os sintomas nasofarĂngeos em pacientes com SAOS. MĂTODO: Foram avaliados 35 pacientes (28 homens), com idade de 54 ±10 anos portadores de SAOS moderada a grave diagnosticada atravĂ©s de polissonografia. Os sintomas nasofarĂngeos (espirros, coriza, prurido, obstrução, sangramento e ressecamento nasal e de garganta) foram quantificados atravĂ©s de questionĂĄrio aplicado antes e depois de pelo menos 3 meses de tratamento com CPAP nasal. RESULTADOS: O Ăndice de apnĂ©ia + hipopnĂ©ia foi de 50±25 eventos por hora. Ao menos um sintoma nasofarĂngeo estava presente em 26 pacientes (74%) antes do tratamento. A obstrução nasal foi o sintoma mais comum, presente em 18 pacientes (51%). Dentre os pacientes inicialmente assintomĂĄticos (n = 9), 78% apresentaram alguma reação nasofarĂngea adversa com o tratamento. Em contraste, nos pacientes inicialmente sintomĂĄticos, houve redução significativa da intensidade da obstrução, do ressecamento nasal e de garganta e do sangramento nasal apĂłs o tratamento. CONCLUSĂO: Sintomas nasofarĂngeos sĂŁo freqĂŒentes em pacientes com SAOS. O uso de CPAP pode tanto desencadear sintomas nasofarĂngeos em pacientes assintomĂĄticos, como reduzir sua intensidade nos pacientes com sintomas prĂ©vios.<br>BACKGROUND: Nasal and pharyngeal symptoms are common in patients with obstructive sleep apnoea (OSA) treated with nasal continuous positive airway pressure (CPAP). However, these symptoms are common in OSA patients even before the treatment. OBJECTIVE: Determine the impact of nasal CPAP on nasal and pharyngeal symptoms in OSA patients. METHOD: Thirty-five adult patients (28 males), age 54±10 years old, with OSA diagnosed by polissonography. All patients answered to a questionnaire about the presence and quantification of sneezing, rhinorrhea, nasal pruritus, obstruction and bleeding, nasal and pharyngeal dryness. The questionnaire was answered before and after at least three months of CPAP therapy. RESULTS: The apnea-hypopnea index was 50±25 events per hour. Twenty six patients (74%) presented at least one naso-pharingeal symptom before treatment. Nasal obstruction was the most common symptom, being referred by 18 patients (51%). Among the patients that were initially assymptomatic (n=9), 78% developed adverse nasal reactions to CPAP. In contrast, among the patients that presented nasal symptoms before treatment, there was a significant reduction in nasal obstruction, nasal and throat dryness scores as well as nasal bleeding after CPAP therapy. CONCLUSION: Nasal na pharyngeal symptoms are frequent in OSAS patients. CPAP therapy may originate nasal symptoms in patients previously assymptomatic, as well as reduce the intensity of these symptoms in patients that are previously symptomatic
Predictors of Unprotected Sex Among Female Sex Workers in Madagascar: Comparing Semen Biomarkers and Self-Reported Data
Research on the determinants of condom use and condom non-use generally has relied on self-reported data with questionable validity. We identified predictors of recent, unprotected sex among 331 female sex workers in Madagascar using two outcome measures: self-reports of unprotected sex within the past 48 h and detection of prostate-specific antigen (PSA), a biological marker of recent semen exposure. Multivariable logistic regression revealed that self-reported unprotected sex was associated with three factors: younger age, having a sipa (emotional partner) in the prior seven days, and no current use of hormonal contraception. The sole factor related to having PSA detected was prevalent chlamydial infection (adjusted odds ratio, 4.5; 95% confidence interval, 2.0â10.1). Differences in predictors identified suggest that determinants of unprotected sex, based on self-reported behaviors, might not correlate well with risk of semen exposure. Caution must be taken when interpreting self-reported sexual behavior measures or when adjusting for them in analyses evaluating interventions for the prevention of HIV/STIs